Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of Covaxin across multiple sites in India.
Covaxin clinical trials cross 23,000 subjects
